5 studies found for:    pegph20
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: PEGPH20+ gemcitabine
2 Recruiting PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: PEGPH20+nab-paclitaxel+gemcitabine;   Drug: nab-paclitaxel + gemcitabine
3 Completed Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Condition: Solid Tumor
Intervention: Drug: PEGPH20
4 Completed Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors
Condition: Solid Tumor
Intervention: Drug: PEGPH20
5 Recruiting S1313, Phase IB/II Randomized Study of MFOLFIRINOX + PEGPH20 Vs MFOLFIRINOX Alone in Patients With Good Performance Status Metastatic Pancreatic Adenocarcinoma
Condition: Metastatic Pancreatic Adenocarcinoma
Interventions: Drug: PEGPH20;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Irinotecan;   Drug: 5-fluorouracil

Indicates status has not been verified in more than two years